海洋植物激素对双胆酶抑制的结构和机制见解
Kumju Youn1,2, Legie Mae Soriano3, Mira Jun1,2,3
1Department of Food Science and Nutrition, Dong-A University, Busan 49315, Republic of Korea.
Marine drugs
|January 27, 2026
概括
海洋植物激素,如异丁胺 (IPA) 和酸 (ABA),通过抑制胆酶,对阿尔茨海默氏病 (AD) 呈现有前途. 这些化合物提供了早期干预阿尔茨海默病中胆固醇功能障碍的潜力.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 海洋生物学 海洋生物学
背景情况:
- 胆功能障碍,标志着乙胆酶 (AChE) 和丁胆酶 (BChE) 的升高,是阿尔茨海默病 (AD) 病理学的核心.
- 现有的AD治疗方法在脑透,持续时间和安全性方面存在局限性,需要新的预防策略.
研究的目的:
- 探索海洋植物激素作为阿尔茨海默病中胆固醇失衡的潜在调节剂.
- 评估海洋植物激素对ACHE和BCHE的抑制作用和机制.
主要方法:
- 采用了综合方法,包括酶分析,定量结构-活性关系 (QSAR) 和密度函数理论 (DFT) 计算.
- 进行了分子对接,分子动力学 (MD) 模拟和吸收,分布,新陈代谢,分泌和毒性 (ADMET) 分析.
主要成果:
- 异丁氨酸 (IPA) 和酸 (ABA) 显示出对胆酶的显著抑制活性.
- IPA表现出非竞争性抑制AChE和竞争性抑制BChE,而ABA选择性抑制了非竞争性抑制AChE.
- 分子模拟证实了明显的结合相互作用和构造稳定性,为这两种化合物预测了有利的ADMET配置文件.
结论:
- 海洋植物激素IPA和ABA通过向胆功能障碍,显示出其作为阿尔茨海默病预防剂的潜力.
- 它们独特的抑制机制和有利的安全概况表明它们适合于早期的AD干预.
相关概念视频
Cholinesterases: Distribution and Function
1.0K
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
1.0K
Feedback Inhibition
57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Mechanistic Models: Overview of Compartment Models
371
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
371
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
613
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
613
Enzyme Inhibition
91.9K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.9K
Mechanistic Models: Compartment Models in Individual and Population Analysis
260
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
260


